People taking oral birth control pills may need to take extra precautions to prevent pregnancy, both to reduce the risk of unintended pregnancies, but also the risks associated with taking GLP-1s while pregnant
Measurements should be taken using a validated upper-arm cuff device of appropriate size, after five minutes of rest, with the arm supported at heart level
We also galvanized the clinical side to add their support to this initiative, all of which were instrumental in the code creation and adoption
Subcutaneous semaglutide 1.0 mg and oral semaglutide 14 mg resulted in weight reductions of 4.5 kg and 3.7 kg, respectively, while placebo only resulted in weight reductions of 1.0 kg and 1.4 kg, respectively
The DPP-4 inhibitor CV safety outcome trials have unequivocally demonstrated that DPP-4 inhibition is not associated with any increased risk of major adverse CV events (MACE), with the four trials so far published (124127) having hazard ratios (HR) for the primary outcome of between 0.96 and 1.02 (Table 2)